EMEA Recommends Stronger Depression Language In Acomplia Label
This article was originally published in The Pink Sheet Daily
Agency is seeking to include a contraindication in people with depression or who are being treated with antidepressants.
You may also be interested in...
Company cites confusion over concerns raised by the Endocrinologic and Metabolic Drugs Advisory Committee, which voted against approval June 13.
Sanofi-Aventis’ rimonabant is currently “approvable” at FDA for obesity.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.